Clinical trial
Does Tranexamic Acid Significantly Reduce Total Blood Loss During Proximal Femoral Nailing for the Intertrochanteric Femoral Fracture in the Elderly?
NCT05359172 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Tranexamic Acid Significantly Reduce Total Blood Loss During Proximal Femoral Nailing for the Intertrochanteric Femoral Fracture in the Elderly?
- Lead sponsor
- Haseki Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- July 10, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood loss, hip fractures, intertrochanteric fractures